Search results

This guideline covers the diagnosing and managing of myeloma (including smouldering myeloma and primary plasma cell leukaemia) in people aged 16 and over. It aims to improve care for people with myeloma by promoting the most effective tests and treatments for myeloma and its complications.

Result type

NICE guideline

Last updated

25 October 2018

Evidence-based recommendations on spesolimab (Spevigo) for treating generalised pustular psoriasis flares in adults.

Result type

Technology appraisal guidance

Published

18 June 2025

This guideline covers parenteral nutrition (intravenous feeding) for babies born preterm, up to 28 days after their due birth date and babies born at term, up to 28 days after their birth. Parenteral nutrition is often needed by preterm babies, critically ill babies, and babies who need surgery.

Result type

NICE guideline

Published

26 February 2020

Evidence-based recommendations on negative pressure wound therapy for the open abdomen. This involves using a small pump to remove infected material, stop fluid escaping and help the wound heal.

Result type

Interventional procedures guidance

Published

27 November 2013

This quality standard covers the identification and management of familial and genetic risk and the recognition and management of ovarian, fallopian tube and primary peritoneal cancer or borderline ovarian cancer in women, trans men and non-binary people aged 18 and over with female reproductive organs (ovaries, fallopian tubes or a uterus). It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Last updated

5 February 2025

Evidence-based recommendations on nirmatrelvir plus ritonavir (Paxlovid), sotrovimab (Xevudy) and tocilizumab (RoActemra) for treating COVID-19.

Result type

Technology appraisal guidance

Last updated

1 May 2025

NICE has developed a medtech innovation briefing (MIB) on artificial intelligence for analysing CT brain scans .

Result type

Medtech innovation briefing

Published

17 March 2020

Evidence-based recommendations on remdesivir (Veklury) and tixagevimab plus cilgavimab (Evusheld) for treating COVID-19.

Result type

Technology appraisal guidance

Published

8 May 2024

This guideline sets out an antimicrobial prescribing strategy for adults with leg ulcer infection. It aims to optimise antibiotic use and reduce antibiotic resistance.

Result type

Antimicrobial prescribing guideline

Published

11 February 2020

This guideline covers assessing and managing heavy menstrual bleeding (menorrhagia). It aims to help healthcare professionals investigate the cause of heavy periods that are affecting a woman’s quality of life and to offer the right treatments, taking into account the woman’s priorities and preferences.

Result type

NICE guideline

Last updated

24 May 2021

Evidence-based recommendations on olaparib (Lynparza) with abiraterone for untreated hormone-relapsed metastatic prostate cancer in adults.

Result type

Technology appraisal guidance

Published

7 February 2024

Evidence-based recommendations on chlormethine gel (Ledaga) for treating early-stage mycosis fungoides-type cutaneous T-cell lymphoma in adults.

Result type

Technology appraisal guidance

Published

18 August 2021

Biographies for all current members of the diagnostics advisory committee.

Evidence-based recommendations on raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women.

Result type

Technology appraisal guidance

Last updated

7 February 2018

Evidence-based recommendations on minimally invasive oesophagectomy. This involves making small cuts or holes in the chest wall and inserting a camera and other instruments into the chest cavity to carry out the operation.

Result type

Interventional procedures guidance

Published

28 September 2011